Statement by Union Health Minister Dr Harsh Vardhan on the current situation of COVID pandemic & actions taken by the Government :
As on 11thSeptember, 2020, a total of 45,62,414 confirmed cases and 76,271 deaths (Case Fatality Rate 1.67%) have been reported in India. As many as 35,42,663 (77.65%) cases have recovered. The maximum cases and deaths have been primarily reported from Maharashtra, Andhra Pradesh, Tamil Nadu, Karnataka, Uttar Pradesh, Delhi, West Bengal, Bihar, Telangana, Odisha, Assam , Kerala & Gujarat. All these States have reported more than one lakh cases.
With our endeavor to manage COVID-19 through a whole of government & whole of society approach, India has been able to limit its cases and deaths per million to 3,328 cases per million and 55 deaths per million population respectively , which is one of the lowest in the world as compared to similarly affected countries.
We have now moved from ‘managing travel related cases’ to containing clusters and large outbreaks due to local transmission to wide spread of infection to urban, peri-urban and rural areas.
Under the overall guidance of Hon’ble Prime Minister, Ministry of Home Affairs, Govt. of India has constituted 11 Empowered Groups on 29th March 2020 on different aspects of COVID-19 management in the country to take informed decisions.
Thirteen clinical trials of repurposed drugs and harnessing of traditional knowledge using the modern medicine approach are building a portfolio of therapeutic options for Covid-19 patients. Phase 2 clinical trial of immunomodulator Sepsivac has been completed successfully. Phase 2 clinical trial of the first-ever phytopharmaceutical ACQH is underway. One prophylactic trial of Aswagandha and three trials of Guduchi + Pippali; Yashtimadhu; and polyherbal AYUSH drug (AYUSH-64) are planned on moderately ill Covid19 patients.
An effective vaccine would be the sure shot tool in armamentarium against this disease. On this front, globally, there are around 145 candidate vaccines in preclinical evaluation and currently 35 vaccines in clinical trial. In India, a major focus has been on facilitating the development of COVID19 vaccine. More than 30 vaccine candidates have been supported which are in different stages of development, 3 candidates are in advanced stage of Phase I/II/III trials and more than 4 are in advanced pre-clinical development stage.
I wish to inform this house that the Government is taking all necessary measures to prevent spread of the COVID in India.